ArticleThe American journal of gastroenterology2013
Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.
Article in The American journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 54 citations in OpenAlex.
- Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU.Therapeutic advances in gastroenterology · 2026Article
- Characteristics of Children With Inflammatory Bowel Disease and Coexisting Celiac Disease Seropositivity.Journal of pediatric gastroenterology and nutrition · 2022Article
- Causal association between celiac disease and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study.Frontiers in immunology · 2022Article
- Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.Inflammatory bowel diseases · 2021Article
- Let Food Be Thy Medicine-Its Role in Crohn's Disease.Nutrients · 2021Review
- Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn's disease.Therapeutic advances in gastroenterology · 2021Article
- Prevalence of Celiac Disease in Children and Adolescents With Inflammatory Bowel Disease.Cureus · 2020Article
- Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach.Scientific reports · 2020Article
- Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease.Nutrients · 2020Review
- How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.Frontline gastroenterology · 2020Review
- Micronutrients Dietary Supplementation Advices for Celiac Patients on Long-Term Gluten-Free Diet with Good Compliance: A Review.Medicina (Kaunas, Lithuania) · 2019Review
- Review
- The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.Alimentary pharmacology & therapeutics · 2017Article
- Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.Inflammatory bowel diseases · 2017Article
- Increased Cumulative Incidence of Dermatomyositis in Ulcerative Colitis: a Nationwide Cohort Study.Scientific reports · 2016Article
- Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.Inflammatory bowel diseases · 2016Article
- Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre.BMC gastroenterology · 2015Article
- Incidence of IBD Among Immigrants to Canada and Their Children: Could Gluten Consumption and Celiac Disease Partly Explain the Variation?The American journal of gastroenterology · 2015Article
- Article
- Assessing of Celiac Disease and Nonceliac Gluten Sensitivity.Gastroenterology research and practice · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
objectivesInflammatory bowel disease (IBD) and celiac disease are the two most common immune-mediated gastrointestinal diseases. There is limited knowledge regarding the course of IBD in those with coexisting celiac disease. We conducted this study to determine whether patients with coexisting celiac disease present a unique phenotype of IBD and to examine the frequency of co-occurrence of celiac disease and IBD in comparison with other autoimmune disorders.
methodsThis was a case-control study performed at two tertiary referral centers. Cases comprised of patients with known diagnoses of celiac disease and IBD. Two random IBD controls without celiac disease were selected for each case after matching for IBD type. Disease phenotype and natural history for both Crohn's disease (CD) and ulcerative colitis (UC) were noted from medical record review, and were compared between IBD patients with and without celiac disease.
resultsWe identified a total of 51 patients with IBD (22 UC, 1 indeterminate colitis, 28 CD) and celiac disease. There was no significant difference in the age, gender, or ethnicity between celiac-IBD and controls. Pancolitis was more common in celiac-UC patients as compared with controls (odds ratio (OR) 3.30, 95% confidence interval (CI) 1.05-21.50). There was also a trend toward increased use of immunomodulators (IMMs) among celiac-UC patients than in non-celiac UC controls (OR 2.83, 95% CI 0.95-8.48). No phenotypic differences were found in celiac-CD patients. There were no significant differences in IBD-related medication usage, hospitalizations, or surgeries.
conclusionsPatients with UC and celiac disease were more likely to have pancolitis and had a trend toward greater use of IMMs. Coexisting celiac disease did not influence natural history of CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.